Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RLYB | AMGN | VRTX | REGN | GSK |
| Company | Rallybio Corporaton | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.6600 | 306.79 | 455.00 | 980.16 | 41.22 |
| High | 1.6816 | 311.48 | 471.39 | 1,001.04 | 41.72 |
| Low | 1.5600 | 305.02 | 453.73 | 979.26 | 40.54 |
| Last | 1.5500 | 304.93 | 465.35 | 990.88 | 40.61 |
| Change | -0.1200 | -0.92 | +10.01 | +10.72 | -4.16 |
| % Change | -7.19% | -0.30% | +2.20% | +1.09% | -9.29% |
| Volume | 44,390 | 997,594 | 813,720 | 283,194 | 7,245,430 |
| 20-Day Average Volume | 208,106 | 2,516,858 | 1,199,038 | 375,571 | 3,624,994 |
| Previous Close | 1.6700 | 305.85 | 455.34 | 980.16 | 44.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7250 | 307.89 | 437.63 | 976.42 | 44.54 |
| 20-Day Raw Stochastic | 23.21% | 44.35% | 95.55% | 81.94% | 1.42% |
| 20-Day Relative Strength | 45.51% | 57.28% | 71.21% | 60.29% | 37.79% |
| Weighted Alpha | -77.09 | +35.89 | +43.09 | +32.68 | +14.52 |
| Today's Opinion | 88% Sell | 72% Buy | 88% Buy | 88% Buy | 48% Buy |
| Previous Opinion | 72% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 48% Sell | 16% Sell | 8% Buy | 48% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.64% since 05/24/24 | +0.38% since 05/24/24 | +2.41% since 05/24/24 | +0.70% since 05/24/24 | -9.97% since 05/24/24 |
| Low | 1.4400 on 05/29/24 | 295.49 on 05/30/24 | 435.57 on 05/30/24 | 952.30 on 05/30/24 | 40.54 on 06/03/24 |
| High | 1.6900 on 05/31/24 | 311.41 on 06/03/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.01 on 05/31/24 |
| 1-Month | |||||
| %Chg | -14.21% since 05/03/24 | -1.38% since 05/03/24 | +16.67% since 05/03/24 | +3.64% since 05/03/24 | -6.62% since 05/03/24 |
| Low | 1.4400 on 05/29/24 | 295.49 on 05/30/24 | 394.03 on 05/07/24 | 950.27 on 05/06/24 | 40.54 on 06/03/24 |
| High | 2.0000 on 05/16/24 | 321.44 on 05/15/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -33.47% since 03/01/24 | +9.51% since 03/01/24 | +8.13% since 03/01/24 | +0.92% since 03/01/24 | -3.35% since 03/01/24 |
| Low | 1.4400 on 05/29/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 3.4600 on 04/11/24 | 322.60 on 05/03/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -29.60% since 12/01/23 | +12.68% since 12/01/23 | +33.26% since 12/01/23 | +21.72% since 12/01/23 | +11.07% since 12/01/23 |
| Low | 1.2250 on 02/05/24 | 260.68 on 04/19/24 | 347.51 on 12/04/23 | 802.55 on 12/04/23 | 35.81 on 12/07/23 |
| High | 3.4600 on 04/11/24 | 329.72 on 02/05/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 69,220 | 164,068,656 | 117,501,856 | 107,999,904 | 92,783,136 |
| Shares Outstanding, K | 41,449 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -74,560,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -19,030,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | -1.63 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 05/09/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 05/06/24 | 05/02/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.16 | 29.42 | 26.14 | 10.90 |